 | • レポートコード：MRC2105A033 • 出版社/出版日：Persistence Market Research / 2021年3月 • レポート形態：英文、PDF、270ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査レポートは、世界の呼吸器インターベンション市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症の危機分析、市場分析/予測、価格分析、製品別（電磁ナビゲーション気管支鏡検査（ENB）、IP診断デバイス、IP治療装置）分析、疾患別（喘息、肺癌、COPD、異物抽出、気管・気管支狭窄）分析、エンドユーザー別（病院、呼吸器科クリニック、外来手術センター、診断センター）分析、地域別分析、市場構成分析、競争分析、仮定、調査手法などを掲載しています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症の危機分析 ・市場分析/予測 ・価格分析 ・世界の呼吸器インターベンション市場規模：製品別（電磁ナビゲーション気管支鏡検査（ENB）、IP診断デバイス、IP治療装置） ・世界の呼吸器インターベンション市場規模：疾患別（喘息、肺癌、COPD、異物抽出、気管・気管支狭窄） ・世界の呼吸器インターベンション市場規模：エンドユーザー別（病院、呼吸器科クリニック、外来手術センター、診断センター） ・世界の呼吸器インターベンション市場規模：地域別 ・市場構成分析 ・競争分析 ・仮定 ・調査手法 |
Interventional Pulmonology Market – Scope of Report
Persistence Market Research recently published a market study on the global market for interventional pulmonology. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities, restraints, and detailed information about the market structure. The market study presents exclusive information about how the interventional pulmonology market will grow during the forecast period of 2021-2031.
Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in Persistence Market Research’s study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the market during the forecast period.
The study is relevant for stakeholders in the interventional pulmonology market, including product manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in this space. Stakeholders in the interventional pulmonology market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in the study.
The study also includes statistics as well as facts related to the macro- as well as micro-economic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the market. Furthermore, small businesses and new entrants in the market too can make use of the information presented in this study, based on which, they can make appropriate business decisions to gain momentum in the market.
Key Segments of Market
Persistence Market Research’s study on the interventional pulmonology market offers information divided into four important segments — product, indication, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Product
Electromagnetic Navigation Bronchoscopy (ENB)
IP Diagnostic Devices
Bronchoscopes
Flexible Bronchoscope
Rigid bronchoscope
EBUS
Aspiration Needles
Biopsy Foreceps
Pleuroscopes
Semi-flexible Pleuroscopes
Rigid Pleuroscopes
Others
IP Therapeutic Devices
Airway Stents
Endobronchial Ablation Systems
Pleural Drainage Catheters
Endobronchial Valves
Indication
Asthma
Lung Cancer
COPD
Foreign Body Extraction
Tracheal and Bronchial Stenosis
End User
Hospitals
Pulmonology Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Region
Global
China
U.S.
Europe
Key Questions Answered in Report
Which regions will continue to remain the most profitable regional markets for interventional pulmonology?
Which factors will induce a change in the demand for interventional pulmonology during the assessment period?
How will changing trends impact the interventional pulmonology market?
How can market players capture the low-hanging opportunities in developed regions?
Which companies are leading the interventional pulmonology market?
What are the winning strategies of stakeholders in the market to upscale their position in this landscape?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the interventional pulmonology market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the interventional pulmonology market, and makes Persistence Market Research’s projections on the growth prospects of the market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
4. Key Success Factors
4.1. Value Chain Analysis
4.2. Regulatory Scenario
4.3. Tracheal and Bronchial Stenosis Procedures, By Key Regions
4.4. Key Interventional Pulmonology Procedure Statistics, By key Region
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Spending
5.2. Forecast Factors – Relevance & Impact
5.2.1. Increasing prevalence of Respiratory Diseases
5.2.2. Cost of Treatment
5.2.3. Government Funding to Support Healthcare
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Trends
5.3.4. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 Economic analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue by Product
6.4.2. Revenue by Indication
6.4.3. Revenue by End User
6.4.4. Revenue By Country
6.5. Industrial Outlook
6.6. Economic Impact
6.7. COVID19 Crisis Analysis Probable Future Impact
7. Global Interventional Pulmonology Market Volume (Units) Analysis 2016-2020 and Forecast, 2021-2031
7.1. Historical Market Volume (Units) Analysis, 2016-2020
7.2. Current and Future Market Volume (Units) Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Interventional Pulmonology Market- Pricing Analysis
8.1. Regional Pricing Analysis By Product
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
9. Global Interventional Pulmonology Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) By Product, 2016-2020
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2021-2031
10.3.1. Electromagnetic Navigation Bronchoscopy (ENB)
10.3.2. IP Diagnostic Devices
10.3.2.1. Bronchoscopes
10.3.2.1.1. Flexible Bronchoscope
10.3.2.1.2. Rigid bronchoscope
10.3.2.2. EBUS
10.3.2.3. Aspiration Needles
10.3.2.4. Biopsy Foreceps
10.3.2.5. Pleuroscopes
10.3.2.5.1. Semi-flexible Pleuroscopes
10.3.2.5.2. Rigid Pleuroscopes
10.3.2.6. Others
10.3.3. IP therapeutic devices
10.3.3.1. Airway Stents
10.3.3.2. Endobronchial Ablation Systems
10.3.3.3. Pleural drainage catheters
10.3.3.4. Endobronchial Valves
10.4. Market Attractiveness Analysis By Product
11. Global Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031, By Indication
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) By Availability, 2016-2020
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2021-2031
11.3.1. Asthma
11.3.2. Lung Cancer
11.3.3. COPD
11.3.4. Foreign Body Extraction
11.3.5. Tracheal and Bronchial Stenosis
11.4. Market Attractiveness Analysis By Indication
12. Global Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) By End User , 2016-2020
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User , 2021-2031
12.3.1. Hospitals
12.3.2. Pulmonology Clinics
12.3.3. Ambulatory Surgical Centers
12.3.4. Diagnostic Centers
12.4. Market Attractiveness Analysis By End User
13. Global Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 – 2020
13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 – 2030
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
14.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2021-2031
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Indication
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants – Intensity Mapping
14.6. Drivers and Restraints – Impact Analysis
15. Latin America Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018
15.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2021-2031
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Indication
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants – Intensity Mapping
15.6. Drivers and Restraints – Impact Analysis
16. Europe Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
16.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy 2021-2031
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.1. By Product
16.3.2. By Indication
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants – Intensity Mapping
16.6. Drivers and Restraints – Impact Analysis
17. South Asia Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
17.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy2021-2031
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.1. By Product
17.3.2. By Indication
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants – Intensity Mapping
17.6. Drivers and Restraints – Impact Analysis
18. East Asia Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
18.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2021-2031
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.1. By Product
18.3.2. By Indication
18.3.3. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants – Intensity Mapping
18.6. Drivers and Restraints – Impact Analysis
19. Oceania Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031
19.1. Introduction
19.2. Historical Market Size (US$ Mn Analysis By Market Taxonomy, 2016-2020
19.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2021-2031
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.1. By Product
19.3.2. By Indication
19.3.3. By End User
19.4. Market Attractiveness Analysis
19.5. Key Market Participants – Intensity Mapping
19.6. Drivers and Restraints – Impact Analysis
20. Middle East and Africa Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
20.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2021-2031
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. South Africa
20.3.1.4. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Indication
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.5. Key Market Participants – Intensity Mapping
20.6. Drivers and Restraints – Impact Analysis
21. Key Countries Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031
21.1. U.S. Interventional Pulmonology Market Analysis
21.1.1. By Product
21.1.1. By Indication
21.1.2. By End User
21.2. Canada Interventional Pulmonology Market Analysis
21.2.1. By Product
21.2.1. By Indication
21.2.2. By End User
21.3. Brazil Interventional Pulmonology Market Analysis
21.3.1. By Product
21.3.1. By Indication
21.3.2. By End User
21.4. Mexico Interventional Pulmonology Market Analysis
21.4.1. By Product
21.4.1. By Indication
21.4.2. By End User
21.5. Argentina Interventional Pulmonology Market Analysis
21.5.1. By Product
21.5.1. By Indication
21.5.2. By End User
21.6. U.K. Interventional Pulmonology Market Analysis
21.6.1. By Product
21.6.1. By Indication
21.6.2. By End User
21.7. Germany Interventional Pulmonology Market Analysis
21.7.1. By Product
21.7.1. By Indication
21.7.2. By End User
21.8. France Interventional Pulmonology Market Analysis
21.8.1. By Product
21.8.1. By Indication
21.8.2. By End User
21.9. Italy Interventional Pulmonology Market Analysis
21.9.1. By Product
21.9.1. By Indication
21.9.2. By End User
21.10. Spain Interventional Pulmonology Market Analysis
21.10.1. By Product
21.10.1. By Indication
21.10.2. By End User
21.11. BENELUX Interventional Pulmonology Market Analysis
21.11.1. By Product
21.11.1. By Indication
21.11.2. By End User
21.12. Russia Interventional Pulmonology Market Analysis
21.12.1. By Product
21.12.1. By Indication
21.12.2. By End User
21.13. Japan Interventional Pulmonology Market Analysis
21.13.1. By Product
21.13.1. By Indication
21.13.2. By End User
21.14. China Interventional Pulmonology Market Analysis
21.14.1. By Product
21.14.1. By Indication
21.14.2. By End User
21.15. South Korea Interventional Pulmonology Market Analysis
21.15.1. By Product
21.15.1. By Indication
21.15.2. By End User
21.16. India Interventional Pulmonology Market Analysis
21.16.1. By Product
21.16.1. By Indication
21.16.2. By End User
21.17. ASEAN Interventional Pulmonology Market Analysis
21.17.1. By Product
21.17.1. By Indication
21.17.2. By End User
21.18. Australia Interventional Pulmonology Market Analysis
21.18.1. By Product
21.18.1. By Indication
21.18.2. By End User
21.19. New Zealand Interventional Pulmonology Market Analysis
21.19.1. By Product
21.19.1. By Indication
21.19.2. By End User
21.20. GCC Countries Interventional Pulmonology Market Analysis
21.20.1. By Product
21.20.1. By Indication
21.20.2. By End User
21.21. Turkey Interventional Pulmonology Market Analysis
21.21.1. By Product
21.21.1. By Indication
21.21.2. By End User
21.22. South Africa Interventional Pulmonology Market Analysis
21.22.1. By Product
21.22.1. By Indication
21.22.2. By End User
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies
22.2. Market Concentration
22.3. Market Share Analysis of Top Players
22.4. Market Presence Analysis
22.4.1.1. Regional footprint of Players
22.4.1.2. Method foot print by Players
22.4.1.3. Channel Foot Print by Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Deep Dive
23.2.1. Medtronic Plc
23.2.1.1. Overview
23.2.1.2. Product Portfolio
23.2.1.3. Profitability by Market Segments (Product/Channel/Region)
23.2.1.4. Sales Footprint
23.2.1.5. Strategy Overview
23.2.1.5.1. Marketing Strategy
23.2.1.5.2. Product Strategy
23.2.1.5.3. Channel Strategy
23.2.2. Boston Scientific Corporation
23.2.2.1. Overview
23.2.2.2. Product Portfolio
23.2.2.3. Profitability by Market Segments (Product/Channel/Region)
23.2.2.4. Sales Footprint
23.2.2.5. Strategy Overview
23.2.2.5.1. Marketing Strategy
23.2.2.5.2. Product Strategy
23.2.2.5.3. Channel Strategy
23.2.3. Olympus Corporation
23.2.3.1. Overview
23.2.3.2. Product Portfolio
23.2.3.3. Profitability by Market Segments (Product/Channel/Region)
23.2.3.4. Sales Footprint
23.2.3.5. Strategy Overview
23.2.3.5.1. Marketing Strategy
23.2.3.5.2. Product Strategy
23.2.3.5.3. Channel Strategy
23.2.4. FUJIFILM Corporation
23.2.4.1. Overview
23.2.4.2. Product Portfolio
23.2.4.3. Profitability by Market Segments (Product/Channel/Region)
23.2.4.4. Sales Footprint
23.2.4.5. Strategy Overview
23.2.4.5.1. Marketing Strategy
23.2.4.5.2. Product Strategy
23.2.4.5.3. Channel Strategy
23.2.5. Becton, Dickinson and Company
23.2.5.1. Overview
23.2.5.2. Product Portfolio
23.2.5.3. Profitability by Market Segments (Product/Channel/Region)
23.2.5.4. Sales Footprint
23.2.5.5. Strategy Overview
23.2.5.5.1. Marketing Strategy
23.2.5.5.2. Product Strategy
23.2.5.5.3. Channel Strategy
23.2.6. Smiths Group Plc
23.2.6.1. Overview
23.2.6.2. Product Portfolio
23.2.6.3. Profitability by Market Segments (Product/Channel/Region)
23.2.6.4. Sales Footprint
23.2.6.5. Strategy Overview
23.2.6.5.1. Marketing Strategy
23.2.6.5.2. Product Strategy
23.2.6.5.3. Channel Strategy
23.2.7. Cook Medical
23.2.7.1. Overview
23.2.7.2. Product Portfolio
23.2.7.3. Profitability by Market Segments (Product/Channel/Region)
23.2.7.4. Sales Footprint
23.2.7.5. Strategy Overview
23.2.7.5.1. Marketing Strategy
23.2.7.5.2. Product Strategy
23.2.7.5.3. Channel Strategy
23.2.8. Vygon
23.2.8.1. Overview
23.2.8.2. Product Portfolio
23.2.8.3. Profitability by Market Segments (Product/Channel/Region)
23.2.8.4. Sales Footprint
23.2.8.5. Strategy Overview
23.2.8.5.1. Marketing Strategy
23.2.8.5.2. Product Strategy
23.2.8.5.3. Channel Strategy
23.2.9. Clarus Medical LLC
23.2.9.1. Overview
23.2.9.2. Product Portfolio
23.2.9.3. Profitability by Market Segments (Product/Channel/Region)
23.2.9.4. Sales Footprint
23.2.9.5. Strategy Overview
23.2.9.5.1. Marketing Strategy
23.2.9.5.2. Product Strategy
23.2.9.5.3. Channel Strategy
23.2.10. Huger Medical Instrument Co. Ltd
23.2.10.1. Overview
23.2.10.2. Product Portfolio
23.2.10.3. Profitability by Market Segments (Product/Channel/Region)
23.2.10.4. Sales Footprint
23.2.10.5. Strategy Overview
23.2.10.5.1. Marketing Strategy
23.2.10.5.2. Product Strategy
23.2.10.5.3. Channel Strategy
23.2.11. Taewoong Medical Co. Ltd.
23.2.11.1. Overview
23.2.11.2. Product Portfolio
23.2.11.3. Profitability by Market Segments (Product/Channel/Region)
23.2.11.4. Sales Footprint
23.2.11.5. Strategy Overview
23.2.11.5.1. Marketing Strategy
23.2.11.5.2. Product Strategy
23.2.11.5.3. Channel Strategy
23.2.12. Shanghai AoHua Photoelectricity Endoscope Co., Ltd
23.2.12.1. Overview
23.2.12.2. Product Portfolio
23.2.12.3. Profitability by Market Segments (Product/Channel/Region)
23.2.12.4. Sales Footprint
23.2.12.5. Strategy Overview
23.2.12.5.1. Marketing Strategy
23.2.12.5.2. Product Strategy
23.2.12.5.3. Channel Strategy
23.2.13. Karl Storz
23.2.13.1. Overview
23.2.13.2. Product Portfolio
23.2.13.3. Profitability by Market Segments (Product/Channel/Region)
23.2.13.4. Sales Footprint
23.2.13.5. Strategy Overview
23.2.13.5.1. Marketing Strategy
23.2.13.5.2. Product Strategy
23.2.13.5.3. Channel Strategy
23.2.14. Richard Wolf Corporation
23.2.14.1. Overview
23.2.14.2. Product Portfolio
23.2.14.3. Profitability by Market Segments (Product/Channel/Region)
23.2.14.4. Sales Footprint
23.2.14.5. Strategy Overview
23.2.14.5.1. Marketing Strategy
23.2.14.5.2. Product Strategy
23.2.14.5.3. Channel Strategy
23.2.15. PENTAX Medical
23.2.15.1. Overview
23.2.15.2. Product Portfolio
23.2.15.3. Profitability by Market Segments (Product/Channel/Region)
23.2.15.4. Sales Footprint
23.2.15.5. Strategy Overview
23.2.15.5.1. Marketing Strategy
23.2.15.5.2. Product Strategy
23.2.15.5.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Table 01: Global Interventional Pulmonology Market Volume (in '000 Unit) Analysis 2016-2020 and Forecast 2021-2031, By RegionTable 02: Global Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)
Table 03: Global Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
Table 04: Global Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication
Table 05: Global Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 06: Global Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 07: U.S. Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)
Table 08: U.S. Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
Table 09: U.S. Interventional Pulmonology Market Volume (in ‘000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)
Table 10: U.S. Interventional Pulmonology Market Volume (in ‘000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
Table 11: U.S. Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication
Table 12: U.S. Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 13: China Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)
Table 14: China Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
Table 15: China Interventional Pulmonology Market Volume (in ‘000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)
Table 16: China Interventional Pulmonology Market Volume (in ‘000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
Table 17: China Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication
Table 18: China Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 19: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)
Table 20: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
Table 21: ROW Interventional Pulmonology Market Volume (in ‘000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)
Table 22: ROW Interventional Pulmonology Market Volume (in ‘000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
Table 23: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication
Table 24: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
Table 25: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 26: ROW Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)
Table 27: ROW Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
Table 28: ROW Interventional Pulmonology Market Volume (in ‘000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product(1/2)
Table 29: ROW Interventional Pulmonology Market Volume (in ‘000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
Table 30: ROW Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication
Table 31: ROW Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User